Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Non Operating Income (2022 - 2025)

Neuroone Medical Technologies' Other Non Operating Income history spans 4 years, with the latest figure at $46677.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 396.14% year-over-year to $46677.0; the TTM value through Dec 2025 reached $207761.0, up 133.41%, while the annual FY2025 figure was $170492.0, 36.2% up from the prior year.
  • Other Non Operating Income reached $46677.0 in Q4 2025 per NMTC's latest filing, down from $66594.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $75432.0 in Q2 2025 to a low of -$26909.0 in Q1 2023.
  • Average Other Non Operating Income over 4 years is $33700.5, with a median of $31008.0 recorded in 2024.
  • Peak YoY movement for Other Non Operating Income: plummeted 79.36% in 2024, then soared 396.14% in 2025.
  • A 4-year view of Other Non Operating Income shows it stood at $51583.0 in 2022, then fell by 11.65% to $45575.0 in 2023, then tumbled by 79.36% to $9408.0 in 2024, then skyrocketed by 396.14% to $46677.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Other Non Operating Income are $46677.0 (Q4 2025), $66594.0 (Q3 2025), and $75432.0 (Q2 2025).